Lanza named head of Astellas global regenerative medicine

Dr. Lanza Named Head of Astellas Global Regenerative Medicine

“Robert Lanza, one of the most prominent scientists in the field of stem cell biology, on Monday said he will lead global regenerative medicine research at Astellas Pharma Inc., the Japanese drug maker that acquired his Massachusetts company this month. Lanza will also remain in his current role of chief scientific officer at Astellas-owned Ocata Therapeutics Inc., which is developing stem cell therapies for a broad range of diseases.”

The Boston Globe [Read More]

Lanza gives opening address at the Massachusetts State Science & Engineering Fair

Dr. Lanza Featured on Stephen Hawking\'s Stem Cell Special

Lanza delivered the opening address to the judges and students at the Official Opening of 2015 MSSEF held at the Massachusetts Institute of Technology. MSSEF was founded by the prestigious American Academy of Arts & Sciences and has advanced science literacy and inspired new generations of science and engineering leaders for over six decades. 400 distinguished scientists and engineers served as judges, providing the year-end competition with over $525,000 in scholarships and prizes.

Read More

Lanza’s work voted the top science story of the year

Winner of Discover Magazine’s ‘People’s Choice’ Award

Stem cell breakthrough by Lanza and colleagues was voted the year\’s top story, beating the Ebola outbreak, climate change crisis, entangled photons, cosmic inflation, as well as the year’s other science stories ranging from topics in space exploration to mathematics, technology, paleontology, and the environment.

Read More

Picture of Dr. Lanza
CELLebrity Doctors 2011 Calendar Logo

Dr. Robert Lanza featured in “CELLebrity” Doctors 2011 Calendar

Top U.S. scientists hang their lab coats for stem cell research fundraising efforts. The 2011 “CELLebrity” Doctors Calendar spotlights twelve highly renowned doctors in the U.S. and details the progress that has been made in their prospective medical fields. NOTE: All proceeds from calendar sales benefit SCF and will be earmarked towards funding stem cell research in the United States.

Read More